Advertisement

The Scientist

» clinical trials and developmental biology

Most Recent

image: Clinical Trial Data Repressed

Clinical Trial Data Repressed

By | January 5, 2012

A new study finds that important drug safety data are not seeing the light of day.

0 Comments

image: Lynne-Marie Postovit: Cancer Modeler

Lynne-Marie Postovit: Cancer Modeler

By | January 1, 2012

Assistant Professor, Department of Anatomy and Cell Biology, University of Western Ontario. Age: 34

3 Comments

image: Bioterrorist Battles

Bioterrorist Battles

By | January 1, 2012

A Swiss-based firm may have a back-door way to thwart a bioterrorist attack—by fighting the flu.

9 Comments

image: HIV Study Named Year's Best

HIV Study Named Year's Best

By | December 23, 2011

Science taps a clinical trial that showed the benefits of antiretroviral treatment in HIV patients as 2011's breakthrough of the year.

3 Comments

image: An Eye for Stem Cells

An Eye for Stem Cells

By | December 1, 2011

Japanese researchers are launching an iPS cell trial for an untreatable eye disease, challenging ongoing embryonic stem cell trials.

36 Comments

image: Astronaut Worms Return from Space

Astronaut Worms Return from Space

By | December 1, 2011

After 6 months in orbit, Caenorhabditis elegans return to Earth—alive and well.

3 Comments

image: Eye of Newt

Eye of Newt

By | December 1, 2011

Researchers find that newts are capable of regenerating body parts well into old age.

6 Comments

image: Frank Bradke: Privy to Axon Growth

Frank Bradke: Privy to Axon Growth

By | December 1, 2011

Full Professor and Senior Research Group Leader, German Center for Neurodegenerative Diseases. Age: 42

5 Comments

image: Newts' New Eyes

Newts' New Eyes

By | December 1, 2011

Cut off a newt’s tail or a leg, or remove a lens from its eye, and it grows back. However, whether newts can continue to do this throughout their lives, or lose the ability as they get older, has remained a mystery. 

3 Comments

image: Flow Cytometry for the Masses

Flow Cytometry for the Masses

By | December 1, 2011

Tagging antibodies with rare earth metals instead of fluorescent molecules turns a veteran technique into a high-throughput powerhouse.

3 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
Ingenuity
Ingenuity

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Eppendorf
Eppendorf
Advertisement
The Scientist
The Scientist
Life Technologies